A detailed history of Verdence Capital Advisors LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 13,232 shares of HALO stock, worth $621,374. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,232
Previous 12,980 1.94%
Holding current value
$621,374
Previous $679,000 11.49%
% of portfolio
0.06%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$51.3 - $64.42 $12,927 - $16,233
252 Added 1.94%
13,232 $757,000
Q2 2024

Jul 25, 2024

SELL
$37.81 - $52.4 $2,268 - $3,144
-60 Reduced 0.46%
12,980 $679,000
Q1 2024

Apr 25, 2024

SELL
$33.68 - $41.95 $51,665 - $64,351
-1,534 Reduced 10.53%
13,040 $530,000
Q4 2023

Jan 31, 2024

BUY
$33.32 - $42.1 $4,664 - $5,894
140 Added 0.97%
14,574 $538,000
Q3 2023

Oct 25, 2023

SELL
$36.46 - $44.03 $6,927 - $8,365
-190 Reduced 1.3%
14,434 $551,000
Q2 2023

Jul 28, 2023

BUY
$30.28 - $38.74 $6,237 - $7,980
206 Added 1.43%
14,624 $527,000
Q1 2023

Apr 24, 2023

SELL
$32.86 - $55.7 $11,303 - $19,160
-344 Reduced 2.33%
14,418 $550,000
Q4 2022

Jan 20, 2023

SELL
$40.06 - $59.44 $36,614 - $54,328
-914 Reduced 5.83%
14,762 $0
Q3 2022

Nov 15, 2022

BUY
$38.53 - $51.78 $5,702 - $7,663
148 Added 0.95%
15,676 $620,000
Q2 2022

Aug 08, 2022

BUY
$37.35 - $48.3 $56,286 - $72,788
1,507 Added 10.75%
15,528 $683,000
Q1 2022

May 02, 2022

BUY
$31.97 - $41.06 $8,024 - $10,306
251 Added 1.82%
14,021 $559,000
Q4 2021

Jan 26, 2022

BUY
$31.82 - $40.75 $72,613 - $92,991
2,282 Added 19.86%
13,770 $554,000
Q3 2021

Nov 12, 2021

SELL
$38.47 - $46.42 $269 - $324
-7 Reduced 0.06%
11,488 $467,000
Q2 2021

Aug 06, 2021

SELL
$38.84 - $51.31 $1,398 - $1,847
-36 Reduced 0.31%
11,495 $522,000
Q1 2021

May 11, 2021

SELL
$39.51 - $51.45 $790 - $1,029
-20 Reduced 0.17%
11,531 $481,000
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $4,207 - $7,110
163 Added 1.43%
11,551 $493,000
Q4 2017

Jan 30, 2020

BUY
$16.75 - $20.8 $190,749 - $236,870
11,388
11,388 $231,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.54B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.